Pu Y - Search Results

1

Treatment of two cases with refractory, metastatic intermediate-risk neuroblastoma with isotretenoin alone or observation.

Pinto N, Cipkala DA, Ladd PE, Pu Y, Cohn SL. Pinto N, et al. Among authors: pu y. Pediatr Blood Cancer. 2014 Jun;61(6):1104-6. doi: 10.1002/pbc.24889. Epub 2013 Nov 30. Pediatr Blood Cancer. 2014. PMID: 24293072

2

Computer-assisted Curie scoring for metaiodobenzylguanidine (MIBG) scans in patients with neuroblastoma.

Sokol EA, Engelmann R, Kang W, Pinto N, Starkey A, Lai H, Nadel H, Shulkin BL, Pu Y, Appelbaum D, Yanik GA, Cohn SL, Armato SG 3rd, Volchenboum S. Sokol EA, et al. Among authors: pu y. Pediatr Blood Cancer. 2018 Dec;65(12):e27417. doi: 10.1002/pbc.27417. Epub 2018 Sep 10. Pediatr Blood Cancer. 2018. PMID: 30198643 Free PMC article.

3

Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma.

Trujillo JA, Godfrey J, Hu Y, Huang J, Smith SM, Frigault MJ, DeFilipp Z, Appelbaum D, Pu Y, Feinberg N, Althaus T, Bishop MR, Riedell PA, Kline J. Trujillo JA, et al. Among authors: pu y. Blood. 2021 Jun 17;137(24):3454-3459. doi: 10.1182/blood.2020009148. Blood. 2021. PMID: 33881502 Free PMC article. No abstract available.

4

Prognostic value of metabolic tumor burden in lung cancer.

Obara P, Pu Y. Obara P, et al. Among authors: pu y. Chin J Cancer Res. 2013 Dec;25(6):615-22. doi: 10.3978/j.issn.1000-9604.2013.11.10. Chin J Cancer Res. 2013. PMID: 24385688 Free PMC article. Review.

5

A new PET/CT volumetric prognostic index for non-small cell lung cancer.

Zhang H, Wroblewski K, Jiang Y, Penney BC, Appelbaum D, Simon CA, Salgia R, Pu Y. Zhang H, et al. Among authors: pu y. Lung Cancer. 2015 Jul;89(1):43-9. doi: 10.1016/j.lungcan.2015.03.023. Epub 2015 Apr 9. Lung Cancer. 2015. PMID: 25936471 Free PMC article.

6

Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL.

Rojek AE, Kline JP, Feinberg N, Appelbaum DE, Pu Y, Derman BA, Jakubowiak A, Kosuri S, Liu H, Nawas MT, Smith SM, Bishop MR, Riedell PA. Rojek AE, et al. Among authors: pu y. Clin Lymphoma Myeloma Leuk. 2024 Feb;24(2):83-93. doi: 10.1016/j.clml.2023.09.005. Epub 2023 Sep 16. Clin Lymphoma Myeloma Leuk. 2024. PMID: 37827881

7

Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.

Liao S, Penney BC, Wroblewski K, Zhang H, Simon CA, Kampalath R, Shih MC, Shimada N, Chen S, Salgia R, Appelbaum DE, Suzuki K, Chen CT, Pu Y. Liao S, et al. Among authors: pu y. Eur J Nucl Med Mol Imaging. 2012 Jan;39(1):27-38. doi: 10.1007/s00259-011-1934-6. Epub 2011 Sep 23. Eur J Nucl Med Mol Imaging. 2012. PMID: 21946983

8

FDG-PET/CT findings of a metastatic pituitary tumor.

Ilkhchoui Y, Appelbaum DE, Pu Y. Ilkhchoui Y, et al. Among authors: pu y. Cancer Imaging. 2010 Mar 18;10(1):114-6. doi: 10.1102/1470-7330.2010.0015. Cancer Imaging. 2010. PMID: 20299302 Free PMC article.

9

Pilot Study of 99mTc-labeled Ethylene Dicysteine Deoxyglucose SPECT-CT Imaging in Treatment Response Evaluation in Patients with Locally Advanced Head and Neck Cancer.

Ginat DT, Westiin C, Brisson RJ, Chin CT, Pu Y, Zhang H, De Souza JA. Ginat DT, et al. Among authors: pu y. Cureus. 2017 Apr 11;9(4):e1152. doi: 10.7759/cureus.1152. Cureus. 2017. PMID: 28503388 Free PMC article.

10

An updated and validated PET/CT volumetric prognostic index for non-small cell lung cancer.

Finkle JH, Penney BC, Pu Y. Finkle JH, et al. Among authors: pu y. Lung Cancer. 2018 Sep;123:136-141. doi: 10.1016/j.lungcan.2018.07.019. Epub 2018 Jul 20. Lung Cancer. 2018. PMID: 30089584

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,085 results

Search Page

Filters